5//SEC Filing
OxySure Therapeutics, Inc. 5
Accession 0001547522-16-000215
CIK 0001413797operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:39 PM ET
Size
11.6 KB
Accession
0001547522-16-000215
Insider Transaction Report
Form 5
Ross Julian T
DirectorCEO, President, and Secretary10% Owner
Transactions
- Award
Options (right to buy)
2015-12-31$0.20/sh+1,000,000$200,000→ 2,417,488 totalExercise: $0.20From: 2016-01-01Exp: 2021-01-01→ Common stock (1,000,000 underlying) - Award
Common stock
2015-12-31$0.20/sh+500,000$100,000→ 672,324 total
Holdings
- 172,324
Common stock
- 1,417,488
Options (right to buy)
Exercise: $0.25From: 2014-04-05Exp: 2019-12-05→ Common stock (1,417,488 underlying) - 400,000(indirect: By Trust)
Common stock
- 14,025,761(indirect: Held by JTR Investments, Limited)
Common stock
Footnotes (5)
- [F1]Restricted stock units (RSUs) pursuant to employment agreement dated 1/1/2015.
- [F2]Represents the earliest date(s) that any options became exercisable.
- [F3]Represents the latest date(s) that any vested options expire.
- [F4]Comprises vested options issued pursuant to various employment agreements and related amendments under the Company's 2004 Stock Option Plan.
- [F5]Comprises options issuable pursuant to employment agreement dated 1/1/2015.
Documents
Issuer
OxySure Therapeutics, Inc.
CIK 0001413797
Entity typeoperating
Related Parties
1- filerCIK 0001413797
Filing Metadata
- Form type
- 5
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:39 PM ET
- Size
- 11.6 KB